For regimens of 5 to 10 hyperthermia treatments , improvements in median T90 ( superficial tumors ) and T50 ( deep tumors ) parameters by 1.2-1 .5 degrees C could result in response rates high enough ( compared to radiotherapy alone ) to justify Phase III trials .
